Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents.

@article{Ogimi2011ImmunogenicityOI,
  title={Immunogenicity of influenza vaccine in children with pediatric rheumatic diseases receiving immunosuppressive agents.},
  author={Chikara Ogimi and Risa Tanaka and Akihiko Saitoh and Tsutomu Oh-ishi},
  journal={The Pediatric infectious disease journal},
  year={2011},
  volume={30 3},
  pages={208-11}
}
BACKGROUND Children with rheumatic diseases receiving immunosuppressive therapy are a high-risk group for influenza virus infection; however, few data are available regarding the efficacy and safety of influenza vaccine for those individuals. METHODS This was a prospective study evaluating the immunogenicity and safety of influenza vaccine in 49 children (mean ± standard deviation: 12.1 ± 4.8 years, age range: 0-21 years) with pediatric rheumatic diseases including juvenile idiopathic… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…